PL377524A1 - Zastosowanie substancji L-DOPA, jej pochodnych i zawierający te związki środek leczniczy do profilaktyki schorzeń psychotycznych - Google Patents
Zastosowanie substancji L-DOPA, jej pochodnych i zawierający te związki środek leczniczy do profilaktyki schorzeń psychotycznychInfo
- Publication number
- PL377524A1 PL377524A1 PL377524A PL37752403A PL377524A1 PL 377524 A1 PL377524 A1 PL 377524A1 PL 377524 A PL377524 A PL 377524A PL 37752403 A PL37752403 A PL 37752403A PL 377524 A1 PL377524 A1 PL 377524A1
- Authority
- PL
- Poland
- Prior art keywords
- dopa
- prophylaxis
- medicaments
- derivatives
- compounds
- Prior art date
Links
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title 1
- 208000028017 Psychotic disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10261808A DE10261808A1 (de) | 2002-12-19 | 2002-12-19 | Verwendung von L-DOPA, seiner Derivate und diese Verbindungen enthaltender Arzneimittel zur Prophylaxe psychotischer Erkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL377524A1 true PL377524A1 (pl) | 2006-02-06 |
Family
ID=32478131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL377524A PL377524A1 (pl) | 2002-12-19 | 2003-12-18 | Zastosowanie substancji L-DOPA, jej pochodnych i zawierający te związki środek leczniczy do profilaktyki schorzeń psychotycznych |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1615631A2 (ru) |
| JP (1) | JP2006511558A (ru) |
| CN (1) | CN1756542A (ru) |
| AU (1) | AU2003294664A1 (ru) |
| CA (1) | CA2513077A1 (ru) |
| DE (1) | DE10261808A1 (ru) |
| EA (1) | EA200500957A1 (ru) |
| MX (1) | MXPA05006409A (ru) |
| PL (1) | PL377524A1 (ru) |
| WO (1) | WO2004056306A2 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401842D0 (sv) * | 2004-07-12 | 2004-07-12 | Dizlin Medical Design Ab | Infusion and injection solution of levodopa |
| RS55142B1 (sr) | 2006-02-17 | 2016-12-30 | Ratiopharm Gmbh | Deuterisani derivati kateholamina i medikamenti koji obuhvataju pomenuta jedinjenja |
| CN105078952A (zh) * | 2015-08-10 | 2015-11-25 | 中国康复研究中心 | 一种左旋多巴制剂及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52102431A (en) * | 1976-02-25 | 1977-08-27 | Kyowa Hakko Kogyo Co Ltd | Remedies for mental disorder |
| IE47082B1 (en) * | 1977-07-01 | 1983-12-14 | Merrell Toraude & Co | -acetylenic amino acids |
| US5149786A (en) * | 1989-10-12 | 1992-09-22 | Chiron Corporation | Dopamine releasing protein and antibody |
-
2002
- 2002-12-19 DE DE10261808A patent/DE10261808A1/de not_active Ceased
-
2003
- 2003-12-18 JP JP2004561055A patent/JP2006511558A/ja active Pending
- 2003-12-18 EP EP03785594A patent/EP1615631A2/de not_active Withdrawn
- 2003-12-18 MX MXPA05006409A patent/MXPA05006409A/es unknown
- 2003-12-18 CN CNA2003801066148A patent/CN1756542A/zh active Pending
- 2003-12-18 AU AU2003294664A patent/AU2003294664A1/en not_active Abandoned
- 2003-12-18 CA CA002513077A patent/CA2513077A1/en not_active Abandoned
- 2003-12-18 EA EA200500957A patent/EA200500957A1/ru unknown
- 2003-12-18 PL PL377524A patent/PL377524A1/pl not_active Application Discontinuation
- 2003-12-18 WO PCT/DE2003/004204 patent/WO2004056306A2/de not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200500957A1 (ru) | 2006-02-24 |
| EP1615631A2 (de) | 2006-01-18 |
| WO2004056306A3 (de) | 2004-11-11 |
| CA2513077A1 (en) | 2004-07-08 |
| MXPA05006409A (es) | 2006-05-31 |
| CN1756542A (zh) | 2006-04-05 |
| JP2006511558A (ja) | 2006-04-06 |
| AU2003294664A1 (en) | 2004-07-14 |
| WO2004056306A2 (de) | 2004-07-08 |
| DE10261808A1 (de) | 2004-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166058A0 (en) | Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof | |
| AU2003279338A1 (en) | Phenethanolamine derivatives for the treatment of respiratory diseases | |
| AU2003291992A1 (en) | Phenylethanolamine derivatives for the treatment of respiratory diseases | |
| IL164302A (en) | Substituted benzazoles, compositions and use thereof in the manufacture of a medicament for the inhibition of raf kinase activity | |
| IL179611A (en) | History 1-Aza-bicycloalkyl, their process, their pharmaceutical preparations and their use in the preparation of drugs for the treatment of psychotic disorders | |
| AP2005003283A0 (en) | Indole derivatives useful for the treatment os diseases | |
| HK1082744A1 (en) | Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof | |
| AU2003210428A1 (en) | Phenethanolamine derivatives for treatment of respiratory diseases | |
| HK1076110A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
| PL375964A1 (en) | Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis | |
| TWI345975B (en) | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament | |
| IL162765A (en) | Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use | |
| HK1089671A1 (en) | Novel imidazole derivatives, the production thereof, and the use of the same as a medicament | |
| PT1487828E (pt) | Derivados de morfolinil-ureia para utilização no tratamento de doenças inflamatórias | |
| PT1525193E (pt) | Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide | |
| HK1074444A1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
| TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
| AU2003303217A1 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
| PL377524A1 (pl) | Zastosowanie substancji L-DOPA, jej pochodnych i zawierający te związki środek leczniczy do profilaktyki schorzeń psychotycznych | |
| AU2003294952A8 (en) | 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same | |
| ZA200605302B (en) | Use of pentadienoic acid derivatives for the treatment of hyperuricemia | |
| AU2003242538A1 (en) | Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug | |
| PL371269A1 (en) | 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases | |
| AU2003232844A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases | |
| IL165653A (en) | Compounds, compositions comprising them and use thereof for the manufacture of medicaments for the treatment of inflammatory diseases, disorders and conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |